`
`Elaine Herrmann Blais
`+1 617 570 1205
`eblais@goodwinlaw.com
`
`
`
`
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`
`goodwinlaw.com
`+1 617 570 1000
`
`
`August 18, 2021
`
`VIA ECF
`
`The Honorable Allison D. Burroughs
`United States District Court Judge
`John Joseph Moakley U.S. Courthouse
`1 Courthouse Way
`Boston, MA 02210
`
`
`Re: Teva Pharmaceuticals Int’l GmbH v. Eli Lilly & Co., No. 1:18-cv-12029-ADB
`
`Dear Judge Burroughs:
`
`We write on behalf of Teva to correct an error in Teva’s August 17, 2021 letter to the Court (ECF No.
`141). Specifically, the letter states that “Teva has reached out to Lilly” to discuss the impact of the recent
`Federal Circuit decisions on the instant litigation. Although we did reach out to Lilly to discuss the impact
`of the Federal Circuit decision, we made that request just after our letter to the court was filed. The parties
`have since agreed to meet and confer next week about the impact of the recent Federal Circuit decisions
`on this litigation.
`
`Respectfully Submitted,
`
`/s/ Elaine Herrmann Blais
`
`Elaine Herrmann Blais
`
`Counsel of Record (via ECF)
`
`cc:
`
`
`